These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 25752357
21. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study. Assem M, El Azab G, Rasheed MA, Abdelfatah M, Shastery M. Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042 [Abstract] [Full Text] [Related]
28. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis. Tan WC, Hogan J, Purkayastha SK, Lombard M, Krasner N. Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260 [Abstract] [Full Text] [Related]
29. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B, Melzer E, Keller N, Bar-Meir S. Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [Abstract] [Full Text] [Related]
31. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia. Chan CC, Chien NH, Lee CL, Yang YC, Hung CS, Tu TC, Wu CH. BMC Gastroenterol; 2015 Dec 03; 15():170. PubMed ID: 26635102 [Abstract] [Full Text] [Related]
35. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. Srinarong C, Siramolpiwat S, Wongcha-um A, Mahachai V, Vilaichone RK. Asian Pac J Cancer Prev; 2014 Dec 03; 15(22):9909-13. PubMed ID: 25520127 [Abstract] [Full Text] [Related]
36. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Oderda G, Marinello D, Lerro P, Kuvidi M, de'Angelis GL, Ferzetti A, Cucchiara S, Franco MT, Romano C, Strisciuglio P, Pensabene L. Helicobacter; 2004 Aug 03; 9(4):293-301. PubMed ID: 15270743 [Abstract] [Full Text] [Related]
37. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. Park HG, Jung MK, Jung JT, Kwon JG, Kim EY, Seo HE, Lee JH, Yang CH, Kim ES, Cho KB, Park KS, Lee SH, Kim KO, Jeon SW. Aliment Pharmacol Ther; 2012 Jan 03; 35(1):56-65. PubMed ID: 22066530 [Abstract] [Full Text] [Related]
38. [A multicenter study of Chinese patent medicine wenweishu/yangweishu in the treatment of Helicobacter pylori positive patients with chronic gastritis and peptic ulcer]. "Wenweishu/yangweishu in the Treatment of Helicobacter pylori Positive Patients with Chronic Gastritis and Peptic Ulcer" Study GroupDepartment of Gastroenterology, First Hospital, Peking University, Beijing, China. hufulian@gmail.com, Hu FL. Zhonghua Yi Xue Za Zhi; 2010 Jan 12; 90(2):75-8. PubMed ID: 20356485 [Abstract] [Full Text] [Related]